Bioo Scientific has launched its MyeloAim and NeuroAim transduction reagents for delivery of RNAi agents into myeloid and neuronal cells.
These transduction reagents are able to transduce siRNA to targeted cells both in vitro and in vivo resulting in efficient gene silencing in cells of human, mouse, and rat origin.
The MyeloAim and NeuroAim transduction reagents provide a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules to these cells.
According to Dr. Sandesh Subramanya, Senior Scientist at Bioo Scientific, “The NeuroAim and MyeloAim transduction reagents are the only delivery vehicles available in the market for cell-specific delivery of siRNA and miRNA.
“These are valuable tools for researchers that focus on studies that require delivering therapeutic small RNAs to neuronal cells and myeloid cells. A huge advantage here is that all payload can ‘selectively hit the mark’ by minimising targeting to non-specific tissues and cells, be well tolerated, and provide a high therapeutic index.”
